Jing-Gung Chung

29PUBLICATIONS
13CO-AUTHORS
Cancer cell biologyChemotherapyBiologically active moleculesPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Mar 21, 2022
DNA damage and NF-κB inactivation implicate glycyrrhizic acid-induced G1 phase arrest in hepatocellular carcinoma cells.

Wei-Shu Wang, Yu-Shan Chen, Chen-Yu Kuo

|Oct 09, 2021
The inhibitory effect and mechanism of quetiapine on tumor progression in hepatocellular carcinoma in vivo.

Chun-Min Su, Song-Shei Lin, Hsiao-Chia Wang

|Sep 28, 2021
Ergosta-7,9(11),22-trien-3β-ol Attenuates Inflammatory Responses via Inhibiting MAPK/AP-1 Induced IL-6/JAK/STAT Pathways and Activating Nrf2/HO-1 Signaling in LPS-Stimulated Macrophage-like Cells.

Yi-Ping Huang, Dar-Ren Chen, Wen-Jen Lin

|Sep 05, 2021
Melittin suppresses epithelial-mesenchymal transition and metastasis in human gastric cancer AGS cells via regulating Wnt/BMP associated pathway.

Jye-Yu Huang, Shu-Fen Peng, Fu-Shin Chueh

|Jul 02, 2021
Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway In Vitro and Drosophila.

Wen-Tsong Hsieh, Min-Hsien Hsu, Wen-Jen Lin

|Mar 06, 2021
Imperatorin Interferes with LPS Binding to the TLR4 Co-Receptor and Activates the Nrf2 Antioxidative Pathway in RAW264.7 Murine Macrophage Cells.

Mei-Hsuen Huang, Yu-Hsien Lin, Ping-Chiang Lyu

Pageof 5

Frequent Collaborators

5 joint publications

Fei-Ting Hsu

3 joint publications

Wen-Tsong Hsieh

2 joint publications

Pornsuda Maraming

2 joint publications

Yueh-Hsiung Kuo